Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India Researchers To Test For Local Sources Of Key Tamiflu Ingredient

This article was originally published in PharmAsia News

Executive Summary

Indian scientists believe they are on the threshold of local development of the primary primary ingredient in Roche's Tamiflu (oseltamivir), so far the main treatment for the H1N1 influenza virus. Tamiflu is still under patent protection, so the rest of the ingredients are not public, but shikimic acid taken from the fruit of China's anise tree, is known to be the main one. Indian researchers are searching for local sources of the acid and are setting up commercial trials to determine how much can be extracted from certain Indian trees, and whether there is enough to process in large quantities. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072416

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel